Page 1 of Clinical Trials for ( Keryx AOI Pharmaceuticals AND Inc. ) [SPONSOR-COLLABORATORS], 28 Total Matches
- 1CompletedA Phase II Study of Perifosine in Patients With Relapsed/Refractory Waldenström's MacroglobulinemiaLast Updated: November 10, 2011Condition(s): Waldenström's Macroglobulinemia
- 2CompletedLast Updated: February 7, 2012Condition(s): Multiple Myeloma; Multiple Myeloma in Relapse
- 3CompletedLast Updated: November 10, 2011Condition(s): Renal Cancer; Tumors
- 4Active, not recruitingLast Updated: October 16, 2011Condition(s): Colorectal Cancer
- 5CompletedLast Updated: February 7, 2012Condition(s): Renal Cell Carcinoma
- 6Completed
- 7CompletedLast Updated: November 10, 2011Condition(s): Renal Cancer; GIST
- 8CompletedLast Updated: November 10, 2011Condition(s): Gastrointestinal Stromal Tumors
- 9CompletedLast Updated: February 7, 2012Condition(s): Leukemia
- 10Active, not recruitingLast Updated: November 10, 2011Condition(s): Multiple Myeloma
- 11CompletedLast Updated: November 10, 2011Condition(s): Kidney Cancer
- 12Active, not recruitingLast Updated: October 16, 2011Condition(s): Non Small Cell Lung Cancer; Solid Tumors; Metastatic Breast Cancer; Sarcomas
- 13CompletedLast Updated: November 10, 2011Condition(s): Tumors; Lymphomas
- 14CompletedLast Updated: February 7, 2012Condition(s): Colon Cancer
- 15CompletedLast Updated: November 10, 2011Condition(s): Colon Cancer
- 16Completed
- 17CompletedLast Updated: February 7, 2012Condition(s): Chondrosarcomas; Alveolar Soft Part Sarcomas; Extra Skeletal Myxoid Chondrosarcomas
- 18CompletedLast Updated: February 7, 2012Condition(s): Non Small Cell Lung Cancer
- 19TerminatedLast Updated: February 7, 2012Condition(s): Glioma; Astrocytoma; Oligodendroglioma; Oligoastrocytoma
- 20CompletedLast Updated: February 7, 2012Condition(s): Multiple Myeloma
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Keryx+AOI+Pharmaceuticals%2C+Inc.
